Olga V. Arjanova

Phase 2 Trial of V-5 Immunitor (V5) in Patients with Chronic Hepatitis C Co-infected with HIV and Mycobacterium Tuberculosis

Olga V. Arjanova, Nathalia D. Prihoda, Larisa V Yurchenko et al. · Journal of Vaccines & Vaccination · 2010 · 20 citations · Full text

Open label trial of adjuvant immunotherapy with Dzherelo, Svitanok, and Lizorm, in MDR-TB, XDR-TB and TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOT

Nathalia D. Prihoda, Olga V. Arjanova, L. V. Yurchenko et al. · Journal of Medicinal Plants Research · 2007 · 18 citations · Full text

Tuberculosis Prevention, Immunology, Pharmacotherapy +18

Adjunct Oral Immunotherapy in Patients with Re-Treated, Multidrug-Resistant or HIV-Coinfected TB

Olga V. Arjanova, Nathalia D. Prihoda, Larisa V Yurchenko et al. · Immunotherapy · 2010 · 16 citations

Clinical Symptoms, Immunodeficiencies, Tuberculosis Prevention +19

Clinical Validation of Sublingual Formulations of Immunoxel (Dzherelo) as an Adjuvant Immunotherapy in Treatment of TB Patients

Y. Efremenko, Olga V. Arjanova, Natalia D Prihoda et al. · Immunotherapy · 2012 · 16 citations

Immunohematology, Tb Drugs, Immunodeficiencies +22

Adjunct Immune Therapy of First-Diagnosed TB, Relapsed TB, Treatment-Failed TB, Multidrug-Resistant TB and TB/HIV

Dmytro Butov, Y. Efremenko, Natalia D Prihoda et al. · Immunotherapy · 2012 · 15 citations